2 income and growth investment trusts that could help you achieve financial independence

These investment trusts offer the perfect blend of growth and income to help boost your wealth with little effort.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Merchants Trust (LSE: MRCH) flies under the radar of most investors, but despite the investment trust’s lack of popularity, I believe that it could be a great buy for long-term investors. 

Income and growth 

It offers the perfect blend of income and growth for investors. At the time of writing, its shares support a dividend yield of 5.1% and over the past five years have produced a return of 65%, excluding dividends. 

Today, the company reported its results for the first half ending 31 July, revealing yet another impressive performance. For the first half Merchants’ total net asset value grew by 9.9% and management increased the dividend payout by 2.5% to 12.3p 

I believe Merchants is one of the best and simplest investment trusts around. The company invests in a portfolio of high-yield UK shares, which generate dividend income. This revenue funds the investment trust’s dividend. To help boost returns, it can borrow money and at the end of the first half, long-term debt was £76m. During the first half, this borrowing had a gross beneficial effect on performance of 2.6%, or a net effect of 1.5% after the 0.9% cost of finance and the movement in the market value of debt of -0.2%. 

All in all, I believe that if you’re looking for a low-cost income fund, you can’t go wrong with Merchants. The firm’s portfolio is populated with UK dividend champions such as Royal Dutch Shell, GlaxoSmithKline, and HSBC. Meanwhile, the management fee is a relatively low 0.47%. 

At the time of writing, the shares trade at a 6.1% discount to net asset value, indicating that at this moment, you can buy the trust and its portfolio of high dividend stocks below market value. I believe that this is a highly attractive opportunity. 

Well diversified 

Witan Investment Trust (LSE: WTAN) is much more complicated than the smaller trust. Unlike its income-focused peer, Witan’s management team targets the best returns in all market environments. The portfolio is well diversified with the top five holdings including shareholdings in two private equity firms, a mining fund, the London Stock Exchange and US banking giant JP Morgan. This diversified approach has helped the trust produce a return of 130% for investors, excluding dividends, over the past five years. 

When it comes to income, Witan offers a token dividend yield of 2.01%. However, this payout, coupled with the firm’s strong capital growth over the previous five years, is attractive. I believe that there’s also room for dividend appreciation.

With an annual management fee of 0.75%, Witan is relatively expensive and is currently trading at a tiny discount to net asset value of 1.2%. Still, even though these metrics are disappointing, the trust’s capital growth and diversification more than make up for the high fees in my view. 

The bottom line 

All in all, if you’re looking for two ready-made income and growth portfolios, then it looks as if Witan and Merchants tick all the boxes as funds that will allow you to sit back, relax and watch your wealth grow. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares in GlaxoSmithKline and Royal Dutch Shell. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended HSBC Holdings and Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »